| scholarly article | Q13442814 |
| P2093 | author name string | Green AR | |
| Baldwin HA | |||
| Murray TK | |||
| Cross AJ | |||
| Sarna GS | |||
| De Souza RJ | |||
| P2860 | cites work | The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms | Q28354362 |
| 9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels | Q35755032 | ||
| Drug treatments of dementia | Q38371116 | ||
| Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex | Q42144280 | ||
| Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes | Q42193084 | ||
| The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro | Q42847596 | ||
| Influence of tetrahydro-9-aminoacridine on excitatory amino acid release | Q44130586 | ||
| Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons | Q46223543 | ||
| Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease | Q48161693 | ||
| Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons | Q48195378 | ||
| 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current | Q48208220 | ||
| Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis | Q48505886 | ||
| Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site. | Q51771071 | ||
| Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. | Q52259713 | ||
| Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. | Q54398592 | ||
| Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection | Q68049023 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1946-1950 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses | |
| P478 | volume | 103 |
| Q48244513 | A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. |
| Q40472033 | Clinical Pharmacokinetics of Tacrine |
| Q48360983 | Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling |
| Q46965271 | Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. |
| Q43690891 | Effect of distigmine bromide on the central cholinergic system |
| Q48707439 | Effects of R(−)-1-(benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylamino) ethoxy]ethanol hydrochloride (T-588), a novel cognitive enhancer, on noradrenaline release in rat cerebral cortical slices |
| Q46092796 | Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat |
| Q52546994 | Metrifonate effects on acetylcholine and biogenic amines in rat cortex. |
| Q28378688 | Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine |
| Q40392124 | Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease |
| Q22242019 | The cholinergic hypothesis of Alzheimer's disease: a review of progress |
Search more.